Grown Rogue International (GRUSF) EBT Margin Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -3,775.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,775.00 |
| Dec 31, 2025 | -4.22 Bn |
| Sep 30, 2025 | 796.64 Mn |
| Jun 30, 2025 | 9,097.00 |
| Mar 31, 2025 | 7,625.00 |
| Dec 31, 2024 | 4.22 Bn |
| Jan 31, 2023 | 957.00 |
| Jan 31, 2022 | 9,987.00 |
| Oct 31, 2021 | 37,944.00 |
| Jul 31, 2021 | -6,247.00 |
| Apr 30, 2021 | 676.00 |
| Jan 31, 2021 | -7,039.00 |
| Oct 31, 2020 | -12,937.00 |
| Jul 31, 2020 | 19,251.00 |
| Apr 30, 2020 | 4,370.00 |
| Jan 31, 2020 | 51,431.00 |
| Oct 31, 2019 | -1,382.00 |
| Jul 31, 2019 | -7,394.00 |
| Apr 30, 2019 | 11,313.00 |
| Jan 31, 2019 | -15,669.00 |